Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
NACompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
October 31, 2000
Conditions
Alagille SyndromeCholestasisBiliary Atresia
Interventions
DRUG
magnesium gluconate
DRUG
magnesium sulfate
Trial Locations (1)
45229-3039
Children's Hospital Medical Center - Cincinnati, Cincinnati
All Listed Sponsors
collaborator
Children's Hospital Medical Center, Cincinnati
OTHER
lead
National Center for Research Resources (NCRR)
NIH
NCT00007033 - Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease | Biotech Hunter | Biotech Hunter